Skip to main content
SpringerLink
Log in

Use of generic combination drugs would reduce expenditure

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2016 dollars

Reference

  • Sacks CA, et al. Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents. Journal of the American Medical Association : 21 Aug 2018. Available from: URL: http://dx.doi.org/10.1001/jama.2018.11439

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Use of generic combination drugs would reduce expenditure. PharmacoEcon Outcomes News 811, 35 (2018). https://doi.org/10.1007/s40274-018-5264-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5264-9

Search

Navigation